Johnson & Johnson (JNJ) is trading at $241.30, reflecting a 1.21% increase but a $10.41 decline from its 52-week high of $251.71. With a market cap of $581.20B and a P/E ratio of 21.59, the stock is fairly valued considering its robust EPS growth of 90.56% year-over-year. However, recent earnings miss of $2.46 against expectations of $2.4633 raises concerns about momentum.